Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to $8.2 million.

  • Bolt Biotherapeutics' Net Cash Flow rose 15699.87% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 381542.06%. This contributed to the annual value of -$3.6 million for FY2024, which is 30413.36% down from last year.
  • Bolt Biotherapeutics' Net Cash Flow amounted to $8.2 million in Q3 2025, which was up 15699.87% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Bolt Biotherapeutics' Net Cash Flow peaked at $89.9 million during Q1 2021, and registered a low of -$37.2 million during Q2 2021.
  • In the last 5 years, Bolt Biotherapeutics' Net Cash Flow had a median value of $1.2 million in 2025 and averaged $645473.7.
  • Per our database at Business Quant, Bolt Biotherapeutics' Net Cash Flow surged by 48746.77% in 2021 and then tumbled by 23145.45% in 2024.
  • Bolt Biotherapeutics' Net Cash Flow (Quarter) stood at $3.7 million in 2021, then crashed by 136.77% to -$1.4 million in 2022, then surged by 220.17% to $1.6 million in 2023, then tumbled by 231.45% to -$2.2 million in 2024, then skyrocketed by 475.84% to $8.2 million in 2025.
  • Its Net Cash Flow stands at $8.2 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.2 million for Q1 2025.